Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 802-808

  Ludvigsson, Jonas F ^a,b   Bergquist, Annika ^a   Montgomery, Scott M ^a,b,c   Bahmanyar, Shahram ^a,d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bile duct diseases; Diabetes; Heart; Liver; Primary sclerosing cholangitis

Indexed keywords

ADULT; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COR PULMONALE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; SWEDEN; VEIN DISEASE; ADOLESCENT; AGED; CARDIOVASCULAR DISEASES; CHILD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAMILY; GENETICS; MULTICENTER STUDY; SCLEROSING CHOLANGITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHOLANGITIS, SCLEROSING; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; YOUNG ADULT;

EID: 84896389434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.11.017     Document Type: Article

References (37)

1. T.R. Card, M. Solaymani-Dodaran, and J. West Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study J Hepatol 48 2008 939 944
2. K.M. Boberg, E. Aadland, J. Jahnsen, N. Raknerud, M. Stiris, and H. Bell Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population Scand J Gastroenterol 33 1998 99 103
3. K. Bambha, W.R. Kim, J. Talwalkar, H. Torgerson, J.T. Benson, and T.M. Therneau et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community Gastroenterology 125 2003 1364 1369
4. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider et al. Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
5. U. Broome, R. Olsson, L. Loof, G. Bodemar, R. Hultcrantz, and A. Danielsson et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 1996 610 615
6. M.B. de Valle, E. Bjornsson, and B. Lindkvist Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort Liver Int 32 2012 441 448
7. L.E. Lamberts, M. Janse, E.B. Haagsma, A.P. van den Berg, and R.K. Weersma Immune-mediated diseases in primary sclerosing cholangitis Dig Liver Dis 43 2011 802 806
8. M.W. van der Linden, A.W. Plat, J.A. Erkens, M. Emneus, and R.M. Herings Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004 Value Health 12 2009 909 914
9. D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T.B. Ferguson, and K. Flegal et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 480 486
10. G.A. Donnan, M. Fisher, M. Macleod, and S.M. Davis Stroke Lancet 371 2008 1612 1623
11. E. Sinakos, G. Abbas, R.A. Jorgensen, and K.D. Lindor Serum lipids in primary sclerosing cholangitis Dig Liver Dis 44 2012 44 48
12. R.A. Jorgensen, K.D. Lindor, J.S. Sartin, N.F. LaRusso, and R.H. Wiesner Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis J Clin Gastroenterol 20 1995 215 219
13. P. Fickert, T. Moustafa, and M. Trauner Primary sclerosing cholangitis - the arteriosclerosis of the bile duct? Lipids Health Dis 6 2007 3
14. J.F. Ludvigsson, P. Otterblad-Olausson, B.U. Pettersson, and A. Ekbom The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Eur J Epidemiol 24 2009 659 667
15. R.H. Wiesner, and N.F. LaRusso Clinicopathologic features of the syndrome of primary sclerosing cholangitis Gastroenterology 79 1980 200 206
16. A. Bergquist, S.M. Montgomery, S. Bahmanyar, R. Olsson, A. Danielsson, and S. Lindgren et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis Clin Gastroenterol Hepatol 6 2008 939 943
17. A. Ekbom The Swedish multi-generation register Methods Mol Biol 675 2011 215 220
18. J.F. Ludvigsson, E. Andersson, A. Ekbom, M. Feychting, J.L. Kim, and C. Reuterwall et al. External review and validation of the Swedish national inpatient register BMC Public Health 11 2011 450
19. G. Ragnarson Tennvall, J. Apelqvist, and M. Eneroth The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish inpatient registry with the consequences for cost estimations J Intern Med 248 2000 397 405
20. Zachrisson I, Tibell C, Bang P, Ortqvist E. Prevalence of type 2 diabetes among known patients with diabetes aged 0-18 years in Sweden. International Society for Pediatric and Adolescent Diabetes St Malo, France; 2003.
21. J.F. Ludvigsson, P. Elfstrom, U. Broome, A. Ekbom, and S.M. Montgomery Celiac disease and risk of liver disease: a general population-based study Clin Gastroenterol Hepatol 5 2007 e61
22. M.J. Grainge, J. West, and T.R. Card Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet 375 2010 657 663
23. P. Arner, R. Gunnarsson, S. Blomdahl, and C.G. Groth Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy Diabetes Care 6 1983 23 25
24. M.M. Kaplan, and M.E. Gershwin Primary biliary cirrhosis N Engl J Med 353 2005 1261 1273
25. M. Allocca, A. Crosignani, A. Gritti, G. Ghilardi, D. Gobatti, and D. Caruso et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis Gut 55 2006 1795 1800
26. A.M. Valdes, B. Wapelhorst, P. Concannon, H.A. Erlich, G. Thomson, and J.A. Noble Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians Tissue Antigens 65 2005 115 119
27. T.A. Aly, E. Eller, A. Ide, K. Gowan, S.R. Babu, and H.A. Erlich et al. Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype Diabetes 55 2006 1265 1269
28. J.A. Underhill, P.T. Donaldson, D.G. Doherty, K. Manabe, and R. Williams HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis Hepatology 21 1995 959 962
29. P. Price, C. Witt, R. Allcock, D. Sayer, M. Garlepp, and C.C. Kok et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases Immunol Rev 167 1999 257 274
30. G. Candore, D. Lio, G. Colonna Romano, and C. Caruso Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions Autoimmun Rev 1 2002 29 35
31. T.J. Weismuller, J. Wedemeyer, S. Kubicka, C.P. Strassburg, and M.P. Manns The challenges in primary sclerosing cholangitis - aetiopathogenesis, autoimmunity, management and malignancy J Hepatol 48 2008 S38 S57
32. C. Rupp, A. Mummelthei, P. Sauer, K.H. Weiss, P. Schirmacher, and A. Stiehl et al. Non-IBD immunological diseases are a risk factor for reduced survival in PSC Liver Int 33 2013 86 93
33. E.V. Loftus Jr., W.J. Sandborn, W.J. Tremaine, D.W. Mahoney, A.R. Zinsmeister, and K.P. Offord et al. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study Gastroenterology 110 1996 1496 1502
34. K.J. van Erpecum, S.J. Smits, P.C. van de Meeberg, F.H. Linn, F.H. Wolfhagen, and G.P. vanBerge-Henegouwen et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior Gastroenterology 110 1996 1503 1506
35. S.A. Mitchell, M. Thyssen, T.R. Orchard, D.P. Jewell, K.A. Fleming, and R.W. Chapman Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study Gut 51 2002 567 573
36. J.T. Green, J. Rhodes, K. Ragunath, G.A. Thomas, G.T. Williams, and V. Mani et al. Clinical status of ulcerative colitis in patients who smoke Am J Gastroenterol 93 1998 1463 1467
37. S. Singh, and J.A. Talwalkar Primary sclerosing cholangitis: diagnosis, prognosis, and management Clin Gastroenterol Hepatol 11 2013 898 907